La guida AIFA del 2026 esplicita su questo punto: trattandosi di medicinali soggetti a prescrizione, non possono essere acquistati online (AIFA, 2026)
Cardiovascular Outcomes Trial in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease Trial 8 (NCT02692716) was a multi-center, multi-national, placebo-controlled, double-blind trial
While Mounjaro itself is currently only FDA-approved to help control blood sugar levels, the active ingredient in the medication, tirzepatide, has been approved for weight loss under a different name
How Semaglutide Causes Improved Blood Sugar and Weight Loss Semaglutide was originally developed to improve glycemic control in adults with Type 2 Diabetes and later was approved for weight management because of its efficacy in this area
benefits must always be weighed against these potential risks